| Literature DB >> 16397297 |
Maureen A Sartor1, Aaron M Zorn, Jennifer A Schwanekamp, Danielle Halbleib, Saikumar Karyala, Michael L Howell, Gary E Dean, Mario Medvedovic, Craig R Tomlinson.
Abstract
The recent sequencing of a large number of Xenopus tropicalis expressed sequences has allowed development of a high-throughput approach to study Xenopus global RNA gene expression. We examined the global gene expression similarities and differences between the historically significant Xenopus laevis model system and the increasingly used X.tropicalis model system and assessed whether an X.tropicalis microarray platform can be used for X.laevis. These closely related species were also used to investigate a more general question: is there an association between mRNA sequence divergence and differences in gene expression levels? We carried out a comprehensive comparison of global gene expression profiles using microarrays of different tissues and developmental stages of X.laevis and X.tropicalis. We (i) show that the X.tropicalis probes provide an efficacious microarray platform for X.laevis, (ii) describe methods to compare interspecies mRNA profiles that correct differences in hybridization efficiency and (iii) show independently of hybridization bias that as mRNA sequence divergence increases between X.laevis and X.tropicalis differences in mRNA expression levels also increase.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16397297 PMCID: PMC1325202 DOI: 10.1093/nar/gkj413
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Figure 1Experimental design for the microarray studies. mRNA expression levels from three corresponding biological replicates of X.laevis (Xl) and X.tropicalis (Xt) tissues (ovary and liver) and developmental stages (egg; stage 10, St. 10 and stage 40, St. 40) were compared to each other and with a reference RNA (Ref.). The reference RNA was composed of equal amounts of total RNA of the above tissues and developmental stages for a given Xenopus species. Each double pointed arrow represents three microarray slides, one slide per biological replicate, in which one of the three slides was ‘dye flipped’.
Figure 2A measurement of microarray hybridization efficiencies for X.laevis versus X.tropicalis. (A) The experimental design to determine the hybridization efficiencies of X.laevis transcripts from ovary, liver, egg; stage 10 (St. 10) and stage 40 (St. 40) to the X.tropicalis DNA microarray probes. Corresponding RNA samples from three biological replicates of the tissues and developmental stages for a given Xenopus species were directly compared to each other by microarray analysis. (B) A plot of log average spot intensities from X.laevis (Y-axis) versus X.tropicalis–X.laevis probe sequence similarity (X-axis). (C) A plot of the log-ratio hybridization bias (Y-axis) versus X.tropicalis–X.laevis probe sequence similarity (X-axis). The Y-axis represents the expected offset from actual relative mRNA expression levels (X.tropicalis/X.laevis).
Figure 3Differential mRNA expression levels for X.laevis (Xl) and X.tropicalis (Xt) are correlated with mRNA transcript sequence divergence. (A) The experimental design to determine whether X.laevis and X.tropicalis differential gene expression for ovary, liver, egg, stage 10 (St. 10) and stage 40 (St. 40) is associated with sequence divergence. mRNA from three biological replicates of the tissues and developmental stages for a given Xenopus species were compared with a corresponding reference RNA (Ref.), in turn, the corresponding ratios from each Xenopus species were compared to each other. (B) Predicted relative gene expression levels of X.laevis to X.tropicalis determined from local regression analysis (Y-axis) versus probe sequence similarity (X-axis). Only the 1681 genes described in the text that were significantly changed relative to the corresponding reference RNA were plotted. (C) A plot of the squared correlation coefficient values (Y-axis) versus probe sequence similarity (X-axis). The Y-axis represents the square of the correlation coefficients for the 1681 genes.
Differential mRNA expression levels between X.laevis and X.tropicalis increase as mRNA sequence divergence increases
| Gene Group | Medians of absolute normalized log differences | |||||
|---|---|---|---|---|---|---|
| Egg | Stage 10 | Stage 40 | Liver | Ovary | Bit score range (median) | |
| Group 1 (Higher similarity scores) | 0.46 | 0.51 | 0.61 | 0.87 | 0.32 | 735–4230 (1201) |
| Group 2 (Lower similarity scores) | 0.67 | 0.62 | 0.64 | 1.08 | 0.47 | 34–722 (348) |
aThere were 77 genes in each group.
bOverall P-value = 0.007 from Wilcoxon non-parametric test.
cAbsolute normalized log difference calculation: |log [(Xt / Xt Ref) / (Xl / Xl Ref)]|.
dSignificant difference: P-value <0.05.
Figure 4The gene expression profiles for X.laevis (Xl) and X.tropicalis (Xt) are similar. (A) The experimental design to determine how X.laevis and X.tropicalis compare in their global gene expression profiles for selected tissues (ovary and liver) and developmental stages (egg, stage 10 and stage 40). mRNA levels from three biological replicates from the two tissues and three developmental stages were compared to a reference RNA (Ref.) for a given Xenopus species. The estimates of log [(Xt/Xt Ref)/(Xl/Xl Ref)] for each gene were compared between X.laevis and X.tropicalis to determine correlation coefficients. (B) Histogram representing the correlation coefficients between X.laevis and X.tropicalis using 1681 transcript levels that changed significantly among the different tissues and stages.
The biological process, molecular function, or cellular component involving those genes with the most highly correlated (≥0.90) gene expression levels between X.laevis and X.tropicalis
| GO Gene Category | List hits | List total | Bonferroni | Benjamini FDR | |
|---|---|---|---|---|---|
| Structural molecule activity | 52 | 211 | 0.000 | 0.000 | 0.000 |
| Cytosolic ribosome | 29 | 208 | 0.000 | 0.000 | 0.000 |
| Protein biosynthesis | 46 | 211 | 0.000 | 0.135 | 0.012 |
| Nucleic acid binding | 88 | 211 | 0.000 | 0.142 | 0.012 |
| Ribonucleoprotein complex | 46 | 208 | 0.000 | 0.149 | 0.012 |
| Protein metabolism | 85 | 211 | 0.000 | 0.263 | 0.020 |
| Cytosol | 36 | 208 | 0.001 | 0.725 | 0.051 |
| Binding | 141 | 211 | 0.001 | 0.772 | 0.051 |
| Biosynthesis | 53 | 211 | 0.009 | 1.000 | 0.446 |
aGene Ontology (GO) program ().
bFalse Discovery Rate (18,19).
The 20 genes of the highest (upper tier) and lowest (lower tier) correlation values
| NCBI clone ID | Gene product description | Pearson correlation |
|---|---|---|
| NP_000970.1 | Ribosomal protein L18; 60S ribosomal protein L18 [ | 0.997 |
| NP_009089.2 | NRAS-related gene; upstream of NRAS [ | 0.997 |
| NP_003398.1 | Zinc finger protein 36 | 0.997 |
| NP_115684.1 | Hypothetical protein MGC4189 [ | 0.995 |
| NP_497827.1 | Cytosolic juvenile hormone binding protein subunit like (32.1 kD) (3F243) | 0.995 |
| NP_001001.2 | Ribosomal protein S6; 40S ribosomal protein S6; phosphoprotein NP33 | 0.995 |
| NP_004692.1 | Cyclin B2 [ | 0.995 |
| AAH61315.1 | Unknown (protein for MGC:75795) [ | 0.994 |
| BAC98186.1 | mKIAA1504 protein [ | 0.994 |
| NP_114172.1 | Cyclin B1; G2/mitotic-specific cyclin B1 [ | 0.994 |
| P30985 | Transcription factor 12 (Class A helix–loop–helix transcription factor GE1) | 0.993 |
| NP_001924.2 | Dihydrolipoamide S-succinyltransferase | 0.992 |
| NP_057735.2 | DAPPER1 [ | 0.992 |
| NP_057018.1 | Nucleolar protein NOP5/NOP58 [ | 0.992 |
| NP_014936.1 | Homology to rat S10; Rps10ap [ | 0.992 |
| P98199 | Potential phospholipid-transporting ATPase (ATPase class I type 8B member 2) | 0.992 |
| NP_000995.1 | Ribosomal protein P2; 60S acidic ribosomal protein P2 | 0.991 |
| NP_001025.1 | Ribonucleotide reductase M2 polypeptide [ | 0.991 |
| NP_002257.1 | Karyopherin alpha 2; RAG cohort 1; importin alpha 1 [ | 0.991 |
| XP_232671.2 | Similar to Probable chromodomain-helicase-DNA-binding protein KIAA1416 | 0.991 |
| NP_060695.1 | Homolog of | −0.774 |
| AAA70336.1 | LATS | −0.784 |
| AAH60352.1 | Unknown (protein for MGC:68448) [ | −0.787 |
| NP_733366.1 | CG2139-PB [ | −0.790 |
| NP_077287.1 | Hypothetical protein ET [ | −0.796 |
| NP_150597.1 | Mitochondrial ribosomal protein S36 [ | −0.802 |
| NP_006295.1 | Deleted in split-hand/split-foot 1 region [ | −0.829 |
| NP_057124.2 | CGI-100 protein [ | −0.831 |
| BAC04638.1 | Unnamed protein product [ | −0.837 |
| NP_005889.2 | Membrane component, chromosome 11, surface marker 1 [ | −0.841 |
| XP_358556.1 | Hypothetical protein XP_358556 [ | −0.859 |
| NP_001780.1 | Cell division cycle 25A; Cdc25A; protein-tyrosine-phosphatase [ | −0.865 |
| NP_060590.1 | Armadillo repeat-containing protein [ | −0.869 |
| NP_733778.1 | Muscle-specific beta 1 integrin binding protein [ | −0.890 |
| NP_056299.1 | GCIP-interacting protein p29 [ | −0.896 |
| NP_780399.1 | RIKEN cDNA 2900010J23 [ | −0.905 |
| XP_215053.2 | Similar to D7Wsu128e protein [ | −0.908 |
| NP_068681.1 | Quaking protein [ | −0.912 |
| NP_001800.1 | Centromere protein A; centromere protein A (17kD) [ | −0.935 |
The physiological processes involving the genes (1681 total) that were significantly differentially expressed between X.laevis and X.tropicalis
| Level | GO term | GO description | Correlation | |||
|---|---|---|---|---|---|---|
| Genes | Mean | Median | SD | |||
| 1 | GO:0007275 | Development | 116 | 0.61 | 0.80 | 0.45 |
| 1 | GO:0050789 | Regulation of biological process | 203 | 0.60 | 0.74 | 0.41 |
| 1 | GO:0009987 | Cellular process | 797 | 0.58 | 0.74 | 0.43 |
| 1 | GO:0007582 | Physiological process | 793 | 0.57 | 0.73 | 0.43 |
| 2 | GO:0040007 | Growth | 18 | 0.70 | 0.85 | 0.32 |
| 2 | GO:0050793 | Regulation of development | 13 | 0.69 | 0.84 | 0.29 |
| 2 | GO:0000003 | Reproduction | 17 | 0.54 | 0.83 | 0.57 |
| 2 | GO:0016265 | Death | 36 | 0.67 | 0.82 | 0.35 |
| 2 | GO:0009605 | Response to external stimulus | 51 | 0.65 | 0.81 | 0.40 |
| 2 | GO:0042592 | Homeostasis | 11 | 0.59 | 0.80 | 0.45 |
| 2 | GO:0050794 | Regulation of cellular process | 174 | 0.61 | 0.77 | 0.41 |
| 2 | GO:0009653 | Morphogenesis | 71 | 0.59 | 0.75 | 0.45 |
| 2 | GO:0050791 | Regulation of physiological process | 193 | 0.60 | 0.75 | 0.42 |
| 2 | GO:0030154 | Cell differentiation | 22 | 0.64 | 0.74 | 0.42 |
| 2 | GO:0008152 | Metabolism | 622 | 0.58 | 0.74 | 0.42 |
| 2 | GO:0007154 | Cell communication | 111 | 0.57 | 0.73 | 0.41 |
| 2 | GO:0006950 | Response to stress | 59 | 0.59 | 0.70 | 0.38 |
| 2 | GO:0050790 | Regulation of enzyme activity | 13 | 0.53 | 0.70 | 0.53 |
| 2 | GO:0006928 | Cell motility | 20 | 0.54 | 0.67 | 0.41 |
| 2 | GO:0009719 | Response to endogenous stimulus | 15 | 0.65 | 0.60 | 0.25 |
| 3 | GO:0016049 | Cell growth | 12 | 0.72 | 0.89 | 0.34 |
| 3 | GO:0009628 | Response to abiotic stimulus | 17 | 0.63 | 0.85 | 0.49 |
| 3 | GO:0040008 | Regulation of growth | 11 | 0.68 | 0.84 | 0.31 |
| 3 | GO:0009581 | Detection of external stimulus | 16 | 0.57 | 0.83 | 0.53 |
| 3 | GO:0008219 | Cell death | 36 | 0.67 | 0.82 | 0.35 |
| 3 | GO:0009058 | Biosynthesis | 172 | 0.63 | 0.81 | 0.42 |
| 3 | GO:0019953 | Sexual reproduction | 16 | 0.52 | 0.81 | 0.58 |
| 3 | GO:0019538 | Protein metabolism | 298 | 0.62 | 0.80 | 0.42 |
| 3 | GO:0016043 | Cell organization and biogenesis | 78 | 0.60 | 0.79 | 0.44 |
| 3 | GO:0009607 | Response to biotic stimulus | 45 | 0.64 | 0.75 | 0.34 |
| 3 | GO:0007267 | Cell–cell signaling | 11 | 0.55 | 0.74 | 0.46 |
| 3 | GO:0008283 | Cell proliferation | 47 | 0.56 | 0.74 | 0.46 |
| 3 | GO:0006793 | Phosphorus metabolism | 64 | 0.62 | 0.73 | 0.37 |
| 3 | GO:0006118 | Electron transport | 46 | 0.55 | 0.73 | 0.38 |
| 3 | GO:0007155 | Cell adhesion | 21 | 0.65 | 0.72 | 0.29 |
| 3 | GO:0009887 | Organogenesis | 53 | 0.60 | 0.72 | 0.41 |
| 3 | GO:0019222 | Regulation of metabolism | 123 | 0.57 | 0.70 | 0.42 |
| 3 | GO:0006139 | Nucleobase, nucleoside, nucleotide and nucle | 238 | 0.55 | 0.69 | 0.44 |
| 3 | GO:0007165 | Signal transduction | 89 | 0.56 | 0.69 | 0.41 |
| 3 | GO:0009308 | Amine metabolism | 30 | 0.52 | 0.69 | 0.42 |
| 3 | GO:0006519 | Amino acid and derivative metabolism | 26 | 0.51 | 0.68 | 0.44 |
| 3 | GO:0005975 | Carbohydrate metabolism | 39 | 0.57 | 0.67 | 0.40 |
| 3 | GO:0040011 | Locomotion | 20 | 0.54 | 0.67 | 0.41 |
| 3 | GO:0006810 | Transport | 162 | 0.53 | 0.66 | 0.45 |
| 3 | GO:0006119 | Oxidative phosphorylation | 23 | 0.63 | 0.66 | 0.27 |
| 3 | GO:0009056 | Catabolism | 74 | 0.56 | 0.65 | 0.42 |
| 3 | GO:0009611 | Response to wounding | 17 | 0.56 | 0.63 | 0.41 |
| 3 | GO:0006091 | Generation of precursor metabolites and energy | 83 | 0.53 | 0.61 | 0.39 |
| 3 | GO:0006066 | Alcohol metabolism | 26 | 0.56 | 0.61 | 0.36 |
| 3 | GO:0006082 | Organic acid metabolism | 37 | 0.46 | 0.60 | 0.44 |
| 3 | GO:0006974 | Response to DNA damage stimulus | 14 | 0.63 | 0.60 | 0.24 |
aGene Ontology (GO) program ().
bOverall mean = 0.56.
cOverall median = 0.73.
Figure 5The global gene expression profiles for X.laevis (Xl) and X.tropicalis (Xt) follow parallel temporally-regulated developmental programs. (A) The part of the experimental design used to determine how X.laevis and X.tropicalis compare in their global gene expression profiles for selected developmental stages (egg; stage 10, St. 10 and stage 40, St. 40). mRNA levels from three biological replicates from the three developmental stages for a given Xenopus species were compared with a reference RNA (Ref.) and mRNA from egg was compared with stage 10 and to stage 40 via the reference RNA. (B) Hierarchical tree of genes and heat map of the developmental stages, in which corresponding stage 10 and stage 40 mRNA levels were compared to egg mRNA levels for each Xenopus species. The top 200 ranked genes in each comparison that were at least 50% changed were included. The heat map columns left to right are: X laevis stage 10 versus X.laevis egg, X.tropicalis stage 10 versus X.tropicalis egg, X.laevis stage 40 versus X.laevis egg, and X.tropicalis stage 40 versus X.tropicalis egg. The brackets to the right of the heat map numbered 1–3, designate groups of genes that are contrary to the overall clustering trend and are described in the text.
Correlation coefficients of genes known to be involved in Xenopus development
| Gene ID | Description of development genes | Pearson correlation |
|---|---|---|
| 7812 | NRAS-related gene; upstream of NRAS | 1.00 |
| 51602 | Nucleolar protein NOP5/NOP58 | 0.99 |
| 4678 | Nuclear autoantigenic sperm protein isoform 1 | 0.99 |
| 21974 | Topoisomerase (DNA) II beta | 0.98 |
| 1786 | DNA (cytosine-5-)-methyltransferase 1; DNA methyltransferase 1; DNAmethyltransferase | 0.98 |
| 1466 | Cysteine and glycine-rich protein 2; SmLIM; LIM domain only 5, smooth muscle | 0.98 |
| 175621 | EMB-5, abnormal EMBryogenesis EMB-5 (175.8 kD) (emb-5) | 0.98 |
| 4624 | Myosin heavy chain 6; myosin heavy chain, cardiac muscle alpha isoform | 0.97 |
| 851389 | Required for Start B in mitosis and for meiosis I spindle pole body separation;Cdc36p | 0.97 |
| 1277 | Alpha 1 type I collagen preproprotein | 0.97 |
| 1459 | Casein kinase 2, alpha prime polypeptide | 0.97 |
| 7273 | Titin isoform N2-B; connectin; CMH9, included; cardiomyopathy, dilated 1G | 0.97 |
| 13822 | Unnamed protein product | 0.96 |
| 30096 | Zic1 | 0.95 |
| 5351 | Lysyl hydroxylase precursor; lysine hydroxylase | 0.95 |
| 3149 | High-mobility group box 3; high-mobility group (nonhistone chromosomal) protein4 | 0.95 |
| 172244 | Cytoplasmic Polyadenylation Element-Binding protein (cpb-3) | 0.95 |
| 655 | Bone morphogenetic protein 7 precursor; osteogenic protein 1 | 0.95 |
| 3399 | Inhibitor of DNA binding 3 | 0.94 |
| 326340 | Zygote arrest 1 | 0.94 |
| 70 | Actin, alpha, cardiac muscle precursor | 0.94 |
| 3622 | Inhibitor of growth 1-like | 0.94 |
| 7020 | Transcription factor AP-2 alpha | 0.94 |
| 855568 | Membrane-bound casein kinase I homolog; Yck2p | 0.93 |
| 54766 | B-cell translocation gene 4; putative transcriptional regulator | 0.93 |
| 1301 | Alpha 1 type XI collagen isoform B preproprotein; collagen XI, alpha-1polypeptide | 0.93 |
| 8651 | Suppressor of cytokine signaling 1; STAT induced SH3 protein 1 | 0.93 |
| 4116 | Mago-nashi homolog | 0.92 |
| 23411 | Sirtuin 1; sir2-like 1; sirtuin type 1 | 0.92 |
| 51654 | CDK5 regulatory subunit associated protein 1 isoform a | 0.92 |
| 7784 | Zona pellucida glycoprotein 3 preproprotein | 0.91 |
| 6520 | Solute carrier family 3 (activators of dibasic and neutral amino acidtransport), member 2 | 0.91 |
| 86 | BAF53a; hArpN beta; actin-related protein; BAF complex 53 kDa subunit;BRG1-associated factor | 0.91 |
| 57829 | Zona pellucida glycoprotein 4 preproprotein; zona pellucida B protein | 0.90 |
| 3475 | Interferon-related developmental regulator 1 | 0.90 |
| 854549 | Homolog of chicken calponin, thus the name | 0.89 |
| 70 | Actin, alpha, cardiac muscle precursor | 0.89 |
| 5757 | Prothymosin, alpha (gene sequence 28) | 0.89 |
| 8857 | Fc fragment of IgG binding protein; IgG Fc binding protein | 0.89 |
| 12505 | CD44 antigen precursor (Phagocytic glycoprotein I) (PGP-1) (HUTCH-I) | 0.88 |
| 323630 | Similar to dishevelled 2, dsh homolog | 0.87 |
| 64603 | T-box transcription factor eomesodermin | 0.87 |
| 6678 | Secreted protein, acidic, cysteine-rich (osteonectin) | 0.87 |
| 4729 | NADH dehydrogenase (ubiquinone) flavoprotein 224 kDa | 0.87 |
| 984 | Cell division cycle 2-like 1 (PITSLRE proteins); Cell division cycle 2-like 1 | 0.86 |
| 3491 | Cysteine-rich, angiogenic inducer, 61 | 0.85 |
| 2266 | Fibrinogen, gamma chain isoform gamma-A precursor | 0.85 |
| 20687 | 0.85 | |
| 23481 | Pescadillo homolog 1, containing BRCT domain | 0.85 |
| 174044 | SMAll body size SMA-6, Serine-threonine kinase, transforming growth factor betatype I receptor | 0.84 |
| 10361 | Nucleoplasmin 2 | 0.83 |
| 180357 | ForKHead transcription factor family member, defective PHArynx development | 0.82 |
| 6159 | Ribosomal protein L29; 60S ribosomal protein L29; heparin/heparansulfate-interacting protein | 0.82 |
| 176688 | Serine/arginine rich splicing factor SF2, substrate of the SR protein kinaseSPK-1 (28.7 kDa) | 0.82 |
| 1278 | Alpha 2 type I collagen; Collagen I, alpha-2 polypeptide; Collagen of skin,tendon and bone, alpha-2 chain | 0.81 |
| 5292 | Pim-1 oncogene; Oncogene PIM1 | 0.80 |
| 54993 | Zinc finger protein 29 | 0.80 |
| 51399 | Synbindin; TRS23 homolog; hematopoietic stem/progenitor cell protein 172 | 0.80 |
| 70 | Actin, alpha, cardiac muscle precursor | 0.79 |
| 6658 | SRY (sex determining region Y)-box 3; transcription factor SOX-3 | 0.78 |
| 3398 | Inhibitor of DNA binding 2; inhibitor of differentiation 2; DNA-binding proteininhibitor ID2 | 0.77 |
| 54514 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4; VASA protein | 0.76 |
| 26578 | Osteoclast stimulating factor 1 | 0.75 |
| 10643 | IGF-II mRNA-binding protein 3; KH domain containing protein overexpressed incancer | 0.75 |
| 5743 | Prostaglandin-endoperoxide synthase 2 precursor; prostaglandin G/H synthase andcyclooxygenase | 0.75 |
| 6227 | Ribosomal protein S21; 40S ribosomal protein S21 | 0.74 |
| 8943 | Adaptor-related protein complex 3, delta 1 subunit; adaptin, delta | 0.73 |
| 5515 | Protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform | 0.72 |
| 6223 | Ribosomal protein S19; 40S ribosomal protein S19 | 0.72 |
| 5052 | Peroxiredoxin 1; natural killer-enhancing factor A; proliferation-associatedgene A | 0.71 |
| 2010 | Emerin | 0.71 |
| 2147 | Coagulation factor II precursor; prothrombin | 0.70 |
| 1209 | Cleft lip and palate associated transmembrane protein 1 | 0.68 |
| 1281 | Alpha 1 type III collagen; Collagen III, alpha-1 polypeptide; collagen, fetal | 0.67 |
| 27289 | GTP-binding protein RHO6 | 0.67 |
| 80781 | Alpha 1 type XVIII collagen isoform 2 precursor; endostatin | 0.65 |
| 652 | Bone morphogenetic protein 4 preproprotein; bone morphogenetic protein 2B | 0.63 |
| 856856 | Suppressor of Choline SynthesisLikely to be involved in regulating INO1expression | 0.62 |
| 859 | Caveolin 3; M-caveolin; caveolin-3 | 0.61 |
| 851676 | Brain Modulosignalin Homolog; Bmh2p [ | 0.60 |
| 176702 | Human Mortality factor-Related Gene related (38.3 kDa) (mrg-1) | 0.59 |
| 35070 | Cadherin-N CG7100-PH | 0.58 |
| 43510 | Kayak CG15509-PB | 0.54 |
| 2195 | FAT gene product | 0.53 |
| 6665 | SRY (sex determining region Y)-box 15; SRY (sex determining region Y)-box 20 | 0.51 |
| 1994 | ELAV-like 1; embryonic lethal, abnormal vision, | 0.50 |
| 5274 | Serine (or cysteine) proteinase inhibitor, clade I (neuroserpin), member 1;protease inhibitor 12 (neuroserpin) | 0.50 |
| 4733 | Developmentally regulated GTP binding protein 11 | 0.50 |
| 6997 | Teratocarcinoma-derived growth factor 1 | 0.45 |
| 11146 | FKBP-associated protein isoform FAP68; FK506-binding protein-associated protein;glomulin | 0.44 |
| 1634 | Decorin isoform b precursor; dermatan sulphate proteoglycans II | 0.41 |
| 694 | B-cell translocation protein 1 | 0.30 |
| 10856 | RuvB-like 2; erythrocyte cytosolic protein, 51-KD; TBP-interacting protein,48-KD; Reptin52 | 0.24 |
| 3852 | Keratin 5; Keratin-5; 58 kda cytokeratin; keratin, type II cytoskeletal 5;cytokeratin 5 | 0.23 |
| 7125 | Troponin C2, fast | 0.19 |
| 173233 | UNCoordinated locomotion UNC-59, septin (52.9 kDa) (unc-59) | 0.12 |
| 7092 | Tolloid-like 1 | 0.09 |
| 2879 | Glutathione peroxidase 4; phospholipid hydroperoxidase; sperm nucleusglutathione peroxidase | 0.03 |
| 1655 | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 5 | 0.00 |
| 224 | Aldehyde dehydrogenase 3A2; aldehyde dehydrogenase 10; fatty aldehydedehydrogenase | 0.00 |
| 928 | CD9 antigen; motility related protein; leukocyte antigen MIC3 | −0.01 |
| 43383 | Fork head CG10002-PA [Drosophila melanogaster] | −0.01 |
| 8861 | LIM domain binding 1; carboxy terminal LIM domain protein 2; LIM domain-bindingfactor-1 | −0.03 |
| 41062 | Polychaetoid CG31349-PA | −0.05 |
| 5931 | Retinoblastoma binding protein 7 | −0.07 |
| 4637 | Smooth muscle and non-muscle myosin alkali light chain isoform 1 | −0.08 |
| 7171 | Tropomyosin 4 | −0.10 |
| 7168 | Tropomyosin 1 (alpha) | −0.30 |
| 8324 | Frizzled 7; frizzled (Drosophila) homolog 7 | −0.51 |
| 4869 | Nucleophosmin (nucleolar phosphoprotein B23, numatrin); Nucleophosmin 1 | −0.51 |
| 4738 | Neural precursor cell expressed, developmentally down-regulated 8 | −0.52 |
| 179788 | Cadherin protein like | −0.53 |
| 51588 | Protein inhibitor of activated STAT protein PIASy | −0.64 |
| 7979 | Deleted in split-hand/split-foot 1 region | −0.83 |
| 19317 | Quaking protein | −0.91 |